Global Real World Leverage Adelphi Real World’s established 25+ year expertise in real world evidence across Europe, USA, Asia, and Latin America to pursue multi-region studies and multinational client opportunities in life sciences.

DSP Led Differentiation Focus on selling the value of Disease Specific Programmes and tailored non-interventional studies to inform Health Outcomes, Medical Affairs, and Market Access teams, highlighting faster, domain-specific insights.

Full Lifecycle Coverage Position Adelphi as a partner capable of supporting evidence needs across the entire compound lifecycle, from early development strategy to domestic tactical implementation.

Data & Tech Edge Highlight the tech stack including Power BI, SAS, Google Cloud, and Azure to reassure clients about robust analytics, scalable data processing, and seamless integration with existing systems.

Strategic Partnerships Target relationships with market access, health outcomes, and medical affairs leaders in mid-to-large pharma and biotech, emphasizing nd evidence-driven decision making and long-term collaboration potential.